netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Introduction

Welcome to the formulary

Useful Links

 

 

Specialty guides for patient management during the coronavirus pandemic

NICE Coronavirus (COVID-19) Guidance

 

COVID-19 Medicines Summaries

 

NHS England coronavirus guidance for clinicians and NHS managers 

 

 

SE London Area Prescribing Committee homepage

 

 

Compliance with NICE technology appraisals

 

News Feed

Nov 20 - APC Recommendation: Melatonin 1mg and 5mg prolonged release tablets (Slenyto®) for managing insomnia in children and adolescents (aged 2 years to 18 years)


Nov 20 - APC Recommendation: Budesonide 3mg gastro-resistant capsules (Budenofalk® 3mg) for the management of autoimmune hepatitis in adults


Oct 20 - MHRA Drug Safety Update: 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity


Oct 20 - MHRA Drug Safety Update: Flucytosine (Ancotil): new contraindication in patients with DPD deficiency


Oct 20 - MHRA Drug Safety Update: Niraparib (Zejula▼): reports of severe hypertension and posterior reversible encephalopathy syndrome (PRES), particularly in early treatment


Oct 20 - MHRA Drug Safety Update: Dolutegravir (Tivicay▼, Triumeq▼, Juluca▼): updated advice on increased risk of neural tube defects


>>> more news

Welcome to the South East London Joint Medicines Formulary

This formulary is a prescribing list that includes the names of medicines approved by the Joint Formulary Committee and South East London Area Prescribing Committee for use at:

  • Guy’s and St Thomas’ NHS Foundation Trust (GSTFT)
  • King’s College Hospital NHS Foundation Trust (KCH)
  • Lewisham and Greenwich NHS Trust (LGT)
The availability of medicines approved by the Joint Formulary Committee and Area Prescribing Committee is subject to funding arrangements and clinical practice in individual Trusts. Availability in each Trust is indicated with each drug entry. For formulary products used less commonly, there maybe a 24-hour delay before the product is available on site as stocks may not be routinely kept.

This formulary does not contain the information necessary for prescribing, dispensing or administration. It should be used in conjunction with the British National Formulary (BNF), supplemented as necessary from specialist publications and manufacturers’ Summaries of Product Characteristics (SPC), local guidelines and national guidelines. It is intended for use by prescribers who have the necessary training and experience to interpret the information it provides.

Supplementary information is available from local Medicines Information/Formulary services:

  • Guy’s and St Thomas’ NHS Foundation Trust (Medicines Information extensions 83849, 83855, 88750; Formulary extension 83854 - outside line 020 7188 3854)
  • King’s College Hospital NHS Foundation Trust (extension 30355)
  • Lewisham and Greenwich NHS Trust (Medicines Information 020 8836 4900; Formulary 020 8836 4847).

Unlicensed medicines/uses

Unlicensed medicines or uses of licensed products that fall outside the marketing authorisation have been included for use in specific clinical settings, where these have been approved for formulary inclusion. Prescribers must take full responsibility for prescribing such products and comply with the Unlicensed Medicines Policy as approved at individual Trust level.

Disclaimer

Every attempt has been made to ensure that the information in this formulary is correct, but errors may have occurred.   Where there is doubt, information should be verified against relevant specialist publications


NetFormulary
   Last updated: 24/11/2020 14:26:48.